Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Accumulated Expenses (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Other Accumulated Expenses for 10 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • Quarterly Other Accumulated Expenses fell 21.26% to $3.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Sep 2025, down 21.26% year-over-year, with the annual reading at $37.7 million for FY2024, 596.93% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $3.4 million at Rhythm Pharmaceuticals, down from $4.4 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $38.8 million in Q1 2025, with the low at $229000.0 in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $6.9 million, with a median of $3.4 million recorded in 2025.
  • The sharpest move saw Other Accumulated Expenses surged 723.75% in 2022, then decreased 24.22% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $800000.0 in 2021, then soared by 202.38% to $2.4 million in 2022, then soared by 123.65% to $5.4 million in 2023, then skyrocketed by 596.93% to $37.7 million in 2024, then crashed by 90.99% to $3.4 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $3.4 million, $4.4 million, and $38.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.